Company news
Avita Medical, Inc. news in 2024
Avita Medical, Inc.'s news releases, calls and decks from 2024, newest first.
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
December 22, 2024
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 18, 2024
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 24, 2024
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 11, 2024
AVITA Medical Reports Third Quarter Financial Results
November 6, 2024
AVITA Medical to Announce Third Quarter 2024 Financial Results
October 9, 2024
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
September 11, 2024
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
September 9, 2024
AVITA Medical Reports Second Quarter Financial Results
August 7, 2024
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
July 31, 2024
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
July 30, 2024
AVITA Medical to Announce Second Quarter 2024 Financial Results
July 10, 2024
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
June 30, 2024
AVITA Medical Achieves Milestone with First Case Using RECELL GO
June 4, 2024
AVITA Medical Announces FDA Approval of RECELL GO
May 29, 2024
AVITA Medical Reports First Quarter Financial Results
May 12, 2024
AVITA Medical to Announce First Quarter 2024 Financial Results
April 14, 2024
AVITA Medical Updates Expected First Quarter 2024 Revenue
April 9, 2024
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
February 28, 2024
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
February 28, 2024
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
February 21, 2024
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
January 31, 2024
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
January 9, 2024
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
January 9, 2024
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 3, 2024
Calls in 2024
- Avita Medical (NASDAQ:RCEL) Q3 2024 Earnings Call
Nov 8, 2024
Transcript - Avita Medical (NASDAQ:RCEL) Q2 2024 Earnings Call
Aug 9, 2024
Transcript - Avita Medical (NASDAQ:RCEL) Q1 2024 Earnings Call
May 13, 2024
Transcript - Avita Medical (NASDAQ:RCEL) Q4 2023 Earnings Call
Feb 24, 2024
Transcript - Avita Medical (NASDAQ:RCEL) Q4 2024 Earnings Call
Feb 13, 2024
Transcript
Decks in 2024
- Investor Presentation (December 2024)
Investor deck · 19 slides · Dec 4, 2024
- Q3 2024 Earnings Presentation
Earnings · 19 slides · Nov 13, 2024
- Q3 2024 Earnings Presentation
Earnings · 7 slides · Nov 8, 2024
- Q2 2024 Earnings Presentation
Earnings · 22 slides · Aug 14, 2024
- Q2 2024 Earnings Presentation
Earnings · 9 slides · Aug 9, 2024
- Shareholder Meeting (June 2024)
Shareholder meeting · 13 slides · Jun 5, 2024
- Q1 2024 Earnings Presentation
Earnings · 27 slides · May 22, 2024
- Q1 2024 Earnings Presentation
Earnings · 7 slides · May 13, 2024
- Q4 2023 Earnings Presentation
Earnings · 23 slides · Feb 28, 2024
- Q4 2024 Earnings Presentation
Earnings · 9 slides · Feb 13, 2024
- 42nd Annual J.P. Morgan Healthcare Conference (January 2024)
Conference · 23 slides · Jan 12, 2024